Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock - $0.01 Par Value
-
Shares outstanding
-
46,382,189
-
Number of holders
-
229
-
Total 13F shares, excl. options
-
43,701,330
-
Shares change
-
-707,456
-
Total reported value, excl. options
-
$1,363,473,910
-
Value change
-
-$25,618,497
-
Put/Call ratio
-
385%
-
Number of buys
-
98
-
Number of sells
-
-93
-
Price
-
$31.20
Significant Holders of AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) as of Q3 2021
264 filings reported holding AVNS - AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value as of Q3 2021.
AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) has 229 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43,701,330 shares
of 46,382,189 outstanding shares and own 94% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7,293,900 shares), VANGUARD GROUP INC (5,124,118 shares), Paradice Investment Management LLC (3,087,229 shares), RGM Capital, LLC (2,521,930 shares), DIMENSIONAL FUND ADVISORS LP (2,171,499 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,161,096 shares), Champlain Investment Partners, LLC (2,082,903 shares), STATE STREET CORP (1,890,127 shares), MACQUARIE GROUP LTD (1,725,237 shares), and GOLDMAN SACHS GROUP INC (1,435,695 shares).
This table shows the top 229 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.